Samsung Bioepis Releases Third Quarter 2026 Biosimilar Market Report
As of June 2026, a total of 96 biosimilars across 21 unique biological molecules have been approved in…
Top 1% Investors in South Korea Pounce on Biotech and Samsung Electronics Amid Semiconductor Rout — BigGo Finance
As South Korea’s stock market plunged on concerns over the semiconductor industry outlook, the top 1% of investors…
Keytruda Patent Expires in Two Years; Samsung Bioepis Targets 47 Trillion Won Market with In-House Technology
As Samsung Bioepis secures subcutaneous injection (SC) formulation technology on its own, the global biosimilar competition is expanding…
Samsung Bioepis, Proteina to Develop AI Antibody Drugs
A view of Samsung Bioepis. Photo courtesy of Samsung Bioepis Samsung Bioepis is stepping up its development of…
South Korean companies sponsor Olympiads to build STEM talent pipeline
Sponsorship agreement ceremony for fostering the South Korean national team for the International Biology Olympiad. Courtesy of the…
Samsung Biologics completes biosimilar spinoff to boost competitiveness
Samsung Biologics CEO John Rim speaks during the company’s shareholders meeting held in Incheon on Friday. (Samsung Biologics)…
Samsung Bioepis Says Biosimilars Created 6.7 Trillion Won in Social Value
Samsung Bioepis Sustainability Report. Samsung Bioepis Holdings (0126Z0) created approximately 6.7 trillion won in social and economic value…
Samsung Launches 200 Billion Won Bio Fund to Expand Next-Generation Tech Investment
Samsung Biologics’ Plant 4. Photo courtesy of Samsung Biologics Samsung is establishing a new 200 billion won fund…
Samsung Bioepis, Samsung Medical Center Team Up for AI-Based Drug Target Discovery
Samsung Bioepis President Kim Kyung-ah (left) and Samsung Medical Center Director Park Seung-woo pose for a photo after…
Assessing Sandoz Group (SWX:SDZ) Valuation After Q1 2026 Biosimilar Growth And Samsung Bioepis Partnership
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…
Samsung Epis Holdings Earns ‘AA’ Rating in MSCI ESG Assessment
A view of Samsung Bioepis headquarters. Photo courtesy of Samsung Epis Holdings Samsung Epis Holdings said Friday it…